COMParative ASSessment of p16/Ki-67 DUal Staining Technology in women living with HIV (COMPASS-DUST study)
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
COMParative ASSessment of p16/Ki-67 DUal Staining Technology in women living with HIV (COMPASS-DUST study)
Principal Institution
College of Medicine, University of Lagos
Principal Investigator(s) (PI)
Okunade, Kehinde Sharafadeen
Project Contact Information
Email:
kehindeokunade@gmail.com
Year(s) Awarded
2022–2027
Country
Nigeria
NIH Partners
NCI
Project Description
The adoption of a validated molecular-based p16/Ki-67 dual-staining technology (DUST) protocol could improve screening performance in women living with HIV (WLHIV) and thereby increase screening intervals and minimize the overall cost of screening and procedure-related anxiety due to the fear of cancer.
This research will aim to evaluate the performance of DUST as a new cervical cancer screening method in WLHIV. The K43 career development program will allow access to resources to carry out the research and training activities with the guidance of established mentors and co-mentors in Nigeria and the US, and also develop the capacity to translate the key findings from current and future studies into public health practice application.
Related World Regions / Countries
Related Global Health Research Topics